Polar Capital Holdings’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-350,000
| Closed | -$13.5M | – | 308 |
|
|
2024
Q4 | $13.5M | Hold |
350,000
| – | – | 0.08% | 178 |
|
|
2024
Q3 | $15.8M | Buy |
+350,000
| New | +$15.8M | 0.08% | 163 |
|
|
2022
Q2 | – | Sell |
-303,429
| Closed | -$7.19K | – | 463 |
|
|
2022
Q1 | $7.19K | Hold |
303,429
| – | – | 0.03% | 242 |
|
|
2021
Q4 | $10.4K | Buy |
303,429
+84,493
| +39% | +$2.89K | 0.04% | 225 |
|
|
2021
Q3 | $3.88K | Buy |
218,936
+99,733
| +84% | +$1.77K | 0.02% | 285 |
|
|
2021
Q2 | $5.35K | Buy |
+119,203
| New | +$5.35K | 0.02% | 269 |
|